Cardiotoxin Analog (CTX) IV 6-12

目录号: GC35609纯度: >98.00%同义词: 心脏毒素类似物多肽
Cardiotoxin Analog (CTX) IV 6-12是环磷酰胺类似物(CTX)IV的一部分肽,来源于Naja atra(台湾眼镜蛇)的毒液,是一种独特的心脏毒素类似物。

Cardiotoxin Analog (CTX) IV 6-12
Cas No.: 115722-23-1
规格价格库存数量操作
1mg¥490.00现货
1
5mg¥1,400.00现货
1
10mg¥2,520.00现货
1

文献被引

本产品暂无引用记录;以下为 GlpBio 产品在 Nature / Cell / Science 等顶刊的客户引用样例
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

产品描述 Description

Cardiotoxin Analog (CTX) IV 6-12 is a peptide fragment of cyclophosphamide analog (CTX) IV, derived from the venom of Naja atra, and is a unique cardiotoxin analog[1]. Cardiotoxin Analog (CTX) IV 6-12 has a three-finger ring structure similar to neurotoxins and muscarinic toxins and has cytolytic effects on many cells[2]. Cardiotoxin Analog (CTX) IV 6-12 can cause depolarization and contraction of smooth and skeletal muscles, as well as depolarization of nerve cells[3]. Cardiotoxin Analog (CTX) IV 6-12 is able to induce membrane fusion of vesicles formed by phospholipids such as cardiolipin or sphingomyelin[4]. Cardiotoxin Analog (CTX) IV 6-12 is the only cardiotoxin isoform known to date that has a positively charged residue at the N-terminal amino acid[5]. CTX IV differs from CTX II only by the presence of arginine in place of a leucine residue at position 1[6].

References:
[1] Kaneda N, Sasaki T, Hayashi K. Primary structures of cardiotoxin analogues II and IV from the venom of Naja naja atra[J]. Biochimica et Biophysica Acta (BBA)-Protein Structure, 1977, 491(1): 53-66.
[2] Wu W G. Diversity of cobra cardiotoxin[J]. Journal of Toxicology: Toxin Reviews, 1997, 16(3): 115-134.
[3] Harvey A L. Cardiotoxins from cobra venoms: possible mechanisms of action[J]. Journal of Toxicology: Toxin Reviews, 1985, 4(1): 41-69.
[4] Forouhar F, Huang W N, Liu J H, et al. Structural basis of membrane-induced cardiotoxin A3 oligomerization[J]. Journal of Biological Chemistry, 2003, 278(24): 21980-21988.
[5] Jang J Y, Kumar T K S, Jayaraman G, et al. Comparison of the hemolytic activity and solution structures of two snake venom cardiotoxin analogues which only differ in their N-terminal amino acid[J]. Biochemistry, 1997, 36(48): 14635-14641.
[6] Kumar T K S, Pandian S T K, Jayaraman G, et al. Understanding the structure, function and folding of cobra toxins[J]. PROCEEDINGS-NATIONAL SCIENCE COUNCIL REPUBLIC OF CHINA PART A PHYSICAL SCIENCE AND ENGINEERING, 1999, 23: 1-19.

Cardiotoxin Analog (CTX) IV 6-12是环磷酰胺类似物(CTX)IV的一部分肽,来源于Naja atra(台湾眼镜蛇)的毒液,是一种独特的心脏毒素类似物[1]。Cardiotoxin Analog (CTX) IV 6-12具有类似于神经毒素和毒蕈碱毒素的三指环结构,对许多细胞具有溶细胞作用[2]。Cardiotoxin Analog (CTX) IV 6-12能够引起平滑肌和骨骼肌的去极化和挛缩,以及神经细胞的去极化[3]。Cardiotoxin Analog (CTX) IV 6-12能够诱导由磷脂(例如心磷脂或鞘磷脂)形成的囊泡的膜融合[4]。Cardiotoxin Analog (CTX) IV 6-12是迄今为止已知的唯一在N-末端氨基酸处具有带正电荷残基的心脏毒素同种型[5]。CTX IV与CTX II的唯一区别是,第1位上的亮氨酸残基被精氨酸取代[6]

产品文档 Product Documents

Purity:>98.00%

化学性质Chemical Properties

CAS 号
115722-23-1
同义词
心脏毒素类似物多肽
分子式
C48H70N10O7
分子量
899.13 g/mol
溶解性
100 mg/ml in water
保存条件
Store at -20°C
General tips
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。
储备液的保存方式和期限:-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。
为了提高溶解度,请将管子加热至 37°C,然后在超声波浴中震荡一段时间。
Shipping Condition
评估样品解决方案:配备蓝冰进行发货。所有其他可用尺寸:配备 RT,或根据请求配备蓝冰。

计算工具摩尔浓度 / 稀释 / 分子量 / 单位换算 / 体内配方 / 溶解度

g/mol